The first neighbors of ACE2 (Sartans protein target if they are repurposed for the treatment of COVID-19) are mostly associated with breast carcinoma, melanoma, malignant neoplasms of the breast, hypertensive disease, and ventricular tachycardia. Here, ACE2 is linked to ventricular tachycardia.